Points from Letters: Safety of the Pill

Por Schapira, M.
Publicado em 1970

Measles Vaccination

Por Schapira, M.
Publicado em 1966

Approach to Malignancy in General Practice

Por Schapira, M.
Publicado em 1962

The presence of caeruloplasmin in cancer of the breast and female genital organs.

Por Schapira, M.
Publicado em 1972

Treating multiple sclerosis with amantadine hydrochloride.

Por Schapira, M.
Publicado em 1974

The role of C1, C1-inactivator and C4 in modulating immune precipitation.

Por Schifferli, J A, Steiger, G, Schapira, M
Publicado em 1985

A study of 1-adamantamine hydrochloride during the 1970 Hong Kong influenza epidemic.

Por Schapira, M., Oxford, J. S., Galbraith, A. W.
Publicado em 1971

I-Sce III: a novel group I intron-encoded endonuclease from the yeast mitochondria.

Por Perea, J, Desdouets, C, Schapira, M, Jacq, C
Publicado em 1993

I-Sce III an intron-encoded DNA endonuclease from yeast mitochondria. Asymmetrical DNA binding properties and cleavage reaction.

Por Schapira, M, Desdouets, C, Jacq, C, Perea, J
Publicado em 1993

Value of examining buffy coats for intragranulocytic micro-organisms in patients with fever.

Por Studer, J P, Glauser, M P, Schapira, M
Publicado em 1979

Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.

Por Schapira, M, Ramus, M A, Jallat, S, Carvallo, D, Courtney, M
Publicado em 1986

Human plasma kallikrein and C1 inhibitor form a complex possessing an epitope that is not detectable on the parent molecules: demonstration using a monoclonal antibody.

Por de Agostini, A, Schapira, M, Wachtfogel, Y T, Colman, R W, Carrel, S
Publicado em 1985

Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.

Por Scott, C F, Silver, L D, Schapira, M, Colman, R W
Publicado em 1984

Purified human plasma kallikrein aggregates human blood neutrophils.

Por Schapira, M, Despland, E, Scott, C F, Boxer, L A, Colman, R W
Publicado em 1982

Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation.

Por Wachtfogel, Y T, Abrams, W, Kucich, U, Weinbaum, G, Schapira, M, Colman, R W
Publicado em 1988

A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.

Por de Agostini, A, Patston, P A, Marottoli, V, Carrel, S, Harpel, P C, Schapira, M
Publicado em 1988

Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.

Por de Agostini, A, Lijnen, H R, Pixley, R A, Colman, R W, Schapira, M
Publicado em 1984

Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors

Por Waeber, B., Juillerat-Jeanneret, L., Aubert, J-F., Schapira, M., Nussberger, J., Brunner, H. R.
Publicado em 1989

Fast liver catabolism of C1q in patients with paraproteinaemia and depletion of the classical pathway of complement.

Por Schifferli, J A, Pascual, M, Steiger, G, Schapira, M, Ryser, J E, Estreicher, J, Dash, A
Publicado em 1987

Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment.

Por Schapira, M, Ramus, M A, Waeber, B, Brunner, H R, Jallat, S, Carvallo, D, Roitsch, C, Courtney, M
Publicado em 1987